The aim of this study was to investigate cognitive functions using auditory event-related brain potentials (ERP) in fibromyalgia syndrome (FMS).
The P300 component of ERP was studied in 36 female FMS patients and 22 control subjects. The short form 36 (SF-36) medical outcome study was used to determine quality of life. Number of tender points and disease duration were noted. Cognitive functions were evaluated with P300.
The symptoms were discrepant in FMS (P<0.001). The scores of the eight SF-36 subgroups in FMS patients were significantly lower than in the control group (P<0.001). Fibromyalgia syndrome patients had prolonged latency and reduced amplitude of P300 (P<0.001). No correlation was found between the subgroups of SF-36, tender point count, disease duration, and P300.
The results of our study reveal that FMS affects quality of life and dysfunction in cognitive abilities can be determined by brain event-related potentials.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Allaf AW, Kunbar KL, Hallum NS, Nosratzadeh B, Templeton KD, Pullar T (2002) A case control study examining the role of physical trauma in the onset of fibromyalgia. Rheumatology 41:450–453
Zidar J, Backman E, Bengtsson A, Henriksson KG (1990) Quantitative EMG and muscle tension in painful muscles in fibromyalgia. Pain 40:249–254
Offenbauer M, Stucki G (2000) Physical therapy in the treatment of fibromyalgia. Scand J Rheumatol 113:78–85
Costa D, Dobkin P, Fitzcharles MA, Fortin PR, Beaulieu A, Zummer M, Senecal JL, Goulet JR, Rich E, Choquette D, Clarke A (2000) Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 27:365–372
Wolfe F, Smythe HA, Yunus MB (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172
Raj S, Brovillard B, Simpson C (2000) Dysautonomia among patients with fibromyalgia. A non-invasive assessment. J Rheumatol 27:2660–2665
Millea PJ, Holloway RL (2000) Treating fibromyalgia. Am Fam Physician 62:1575–1582
Crofford LJ, Demitrack MA (1996) Evidence that the abnormalities of central neurohormonal systems are the key to understanding fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 22:267–284
Park D, Glass JM, Minear ME, Crofford LJ (2001) Cognitive function in fibromyalgia. Arthritis Rheum 44:2125–2133
Sletvold H, Stiles TC, Lanro NI (1995) Information processing in primary fibromyalgia, major depression and healthy controls. J Rheum 22:137–142
Lanro NI, Stiles TC, Sletvold H (1997) Memory functions in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42:297–306
Grace GM, Nielson WR, Hopkins M, Berg NA (1999) Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neurophychol 21:477–487
Neuman L, Berzak A, Bushkila D (2000) Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29:400–408
Burckhardt CS, Clark SR, Bennet RM (1993) Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 20:475–479
Pozzessere G, Valle E, Crignis SD, Cordischi VM, Fattapposta F, Rizzo P, Pietravalle P, Cristina G, Morano S, Di Mario U (1991) Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Diabetes 40:952–958
Starr A, Barret G (1987) Disordered auditory short-term memory in man and event-related potentials. Brain 110:935–959
Kurita A, Mochio S, Isogai Y (1995) Changes in auditory P300 event-related potentials in diabetes mellitus. Acta Neurol Scand 92:319–323
Tandon OP, Kumar A, Dhar D, Battacharya A (1997) Event-related evoked potential responses (P300) following epidural methylprednisolone therapy in chronic low back pain. Anaesthesia 52:1173–1176
Demirci S, Savas S (2001) The auditory event-related potentials in episodic and chronic pain sufferers. Eur J Pain 6:239–244
Ozata M, Ozkardes A, Odabasi Z, Beyhan Z, Vural O, Ozdemir C (1997) Auditory event-related brain potentials in hyperthyroidism. Acta Neurol Belg 97:228–231
Ozata M, Odabası Z, Cağlayan S, Ozkardes A, Vural O (1999) Event-related brain potentials in male hypogonadism. J Endocrinol Invest 22:1–6
Yoldas T, Ozgocmen S, Yildizhan H, Yigiter R, Ulvi H, Ardıcoglu O (2003) Auditory P300 event-related potentials in fibromyalgia patients. Yonsei Med J 44:89–93
Ozgocmen S, Yoldas T, Kamanlı A, Yildizhan H, Yigiter R, Ardıcoglu O (2003) Auditory P300 event-related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia. Ann Rheum Dis 62:551–555
Gladman D, Urowitz BM, Gough J, MacKinnon A (1997) Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 24:2145–2148
Dochin E, Coles GH (1988) Is the P300 component a manifestation of context updating? Behav Brain Sci 11:357–374
Neuman L, Buskila D (1997) Measuring the quality of life in women with fibromyalgia: a Hebrew version of the quality of life scale (QOLS). J Musculoskeletal Pain 5:5–17
Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W (1996) Functional status in patients with chronic fatigue syndrome, other fatiguing illness, and healthy individuals. Am J Med 171:364–370
Tandon OP, Kumar S (1993) P3 Event-related cerebral evoked potential in chronic pain patients. Indian J Physiol Pharmacol 37:51–55
Main C (1983) The Modified Somatic Perception Questionnaire (MSPQ). J Psychosom Res 27:503–513
Flor H, Birbaumer N, Turk DC (1990) The psychobiology of chronic pain. Adv Behav Res Ther 12:47–84
About this article
Cite this article
Alanoğlu, E., Ulaş, U.H., Özdağ, F. et al. Auditory event-related brain potentials in fibromyalgia syndrome. Rheumatol Int 25, 345–349 (2005). https://doi.org/10.1007/s00296-004-0443-3
- Cognitive dysfunction
- Brain event-related potentials
- Short form 36